Jim Cramer Says Abbot Is “Going to Have to Give Us a Couple of Reasons on the Call” to Go Higher

I besides privation to perceive from Abbott Labs, and this is tricky, okay? Its stock’s down an astounding 20% for the twelvemonth aft that past conscionable so-so quarter, and a nonaccomplishment and a suit astir its peculiar babe formula. But I don’t cognize if this really, if this banal truly belongs connected the 52-week debased list. I mean, that said, if Abbott’s going to spell higher, it’s going to person to springiness america a mates of reasons connected the call.

A banal marketplace graph. Photo by Alesia Kozik connected Pexels

Abbott Laboratories (NYSE:ABT) develops and sells healthcare products, including generic medicines, diagnostic systems, nutrition brands, cardiovascular and diabetes attraction devices, and neuromodulation technologies. During the November 20, 2025, episode, Cramer discussed the company’s acquisition of Exact Sciences, arsenic helium stated:

This morning, Abbott Labs announced that it’s buying Exact Sciences, that’s the colorectal crab screening company, for astir $21 billion. It’s a 51% premium wherever it was trading earlier we started proceeding speech of the deal. This transaction volition beryllium the largest healthcare woody successful 2 years and the largest diagnostic acquisition ever. Exact Sciences has a large product… Of course, this benignant of woody astir apt would’ve been blocked by Biden’s antitrust regulators if lone due to the fact that the FTC nether Lina Khan seemed reflexively hostile to each mergers. But nether Trump, it’ll astir apt sail through.

Now, normally, an acquired banal lone gets deed hard if they’re paying… for the people with their ain shares. But Abbott’s paying successful cash, and it’s inactive dropped much than $6 implicit the past 2 days since the woody was reported. I deliberation that’s crazy. Abbott has a large spread successful its diagnostic business, and Exact Sciences would plug it. The remainder of the concern is doing rather well. So I deliberation it’s a terrific clip to bash immoderate buying, particularly arsenic erstwhile successful the portfolio, it volition accelerate Abbott’s maturation rate.

While we admit the imaginable of ABT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.